Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale

References

• Miyake M, Shimizu T, Nishimura N, et al. Response to pembrolizumab after dose-Reduced cisplatin plus gemcitabine chemotherapy is inferior to that after carboplatin plus gemcitabine chemotherapy in cisplatin-Unfit patients with advanced urothelial carcinoma. Clin Genitourin Cancer. 2020;20(2):196.e1–196.e9. doi: 10.1016/j.clgc.2021.11.006.
   Web of Science ®Google Scholar
• EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
   Google Scholar
• Powles T, Rosenberg JE, Sonpavde GP, et al. Enfortumab vedotin in previously treated advanced urothelial carcinoma. N Engl J Med. 2021;384(12):1125–1135. doi: 10.1056/NEJMoa2035807.
   PubMed Web of Science ®Google Scholar
• Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs. 2005;9 Suppl 2: S84–S91. doi: 10.1016/j.ejon.2005.09.003.
   PubMedGoogle Scholar
• Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer. 2008;16(3):275–283. doi: 10.1007/s00520-007-0319-7.
   PubMed Web of Science ®Google Scholar
• Speck RM, DeMichele A, Farrar JT, et al. Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies. Support Care Cancer. 2013;21(2):549–555. doi: 10.1007/s00520-012-1551-3.
   PubMed Web of Science ®Google Scholar
• Ensen SB, Mouridsen HT, Bergmann OJ, et al. Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(2):217–226. doi: 10.1016/j.tripleo.2008.04.003.
   PubMed Web of Science ®Google Scholar
• Matsubara N, Yonese J, Kojima T, et al. Japanese subgroup analysis of EV-301: an open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma. Cancer Med. 2023;12(3):2761–2771. doi: 10.1002/cam4.5165.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Uemura M, Kimura T, et al. A phase I study of enfortumab vedotin in japanese patients with locally advanced or metastatic urothelial carcinoma. Invest New Drugs. 2020;38(4):1056–1066. doi: 10.1007/s10637-019-00844-x.
   PubMed Web of Science ®Google Scholar
• Zschäbitz S, Biernath N, Hilser T, et al. Enfortumab vedotin in metastatic urothelial carcinoma: survival and safety in a european multicenter real-world patient cohort. Eur Urol Open Sci. 2023;53:31–37. doi: 10.1016/j.euros.2023.04.018.
   PubMedGoogle Scholar
• Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer. 2001;9(8):575–580. doi: 10.1007/s005200100279.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol. 2010;46(2):77–81. doi: 10.1016/j.oraloncology.2009.11.008.
   PubMed Web of Science ®Google Scholar
• Zabernigg A, Gamper E-M, Giesinger JM, et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist. 2010;15(8):913–920. doi: 10.1634/theoncologist.2009-0333.
   PubMed Web of Science ®Google Scholar
• van Oort S, Kramer E, de Groot JW, et al. Taste alterations and cancer treatment. Curr Opin Support Palliat Care. 2018;12(2):162–167. doi: 10.1097/SPC.0000000000000346.
   PubMed Web of Science ®Google Scholar
• Drareni K, Dougkas A, Giboreau A, et al. Relationship between food behavior and taste and smell alterations in cancer patients undergoing chemotherapy: a structured review. Semin Oncol. 2019;46(2):160–172. doi: 10.1053/j.seminoncol.2019.05.002.
   PubMed Web of Science ®Google Scholar
• Drareni K, Dougkas A, Giboreau A, et al. Chemosensory changes from cancer treatment and their effects on patients’ food behavior: a scoping review. Nutrients. 2019;11(10):2285.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Smutzer G, Doty RL. Understanding the impact of taste changes in oncology care. Support Care Cancer. 2016;24(4):1917–1931. doi: 10.1007/s00520-016-3083-8.
   PubMed Web of Science ®Google Scholar
• Bernhardson BM, Tishelman C, Rutqvist LE. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage. 2007;34(4):403–412. doi: 10.1016/j.jpainsymman.2006.12.010.
   PubMed Web of Science ®Google Scholar
• Kano T, Kanda K. Development and validation of a chemotherapyinduced taste alteration scale. Oncol Nurs Forum. 2013;40(2):E79–E85. doi: 10.1188/13.ONF.E79-E85.
   PubMedGoogle Scholar
• Bamias A, Dafni U, Karadimou A, et al. Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03). Ann Oncol. 2013;24(4):1011–1017. doi: 10.1093/annonc/mds583.
   PubMed Web of Science ®Google Scholar
• Pedersini R, Zamparini M, Bosio S, et al. Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study. Support Care Cancer. 2022;30(8):6955–6961. doi: 10.1007/s00520-022-07091-6.
   PubMed Web of Science ®Google Scholar
• Tokuda Y, Okubo T, Ohde S, et al. Assessing items on the SF-8 Japanese version for health-related quality of life: a psychometric analysis based on the nominal categories model of item response theory. Value Health. 2009;12(4):568–573. doi: 10.1111/j.1524-4733.2008.00449.x.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer. 1998;34(6):810–815. doi: 10.1016/s0959-8049(97)00395-x.
   PubMed Web of Science ®Google Scholar
• Ware J, Kosinski M, Dewey J, et al. How to score and interpret Single-Item health status measures: a manual for users of the SF-8 health survey. Boston: QualyMetric, 2001.
   Google Scholar
• Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. 3rd Edition. Brussels: European Organisation for Research and Treatment of Cancer, 2001.
   Google Scholar
• Steinbach S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies. J Clin Oncol. 2009;27(11):1899–1905. doi: 10.1200/JCO.2008.19.2690.
   PubMed Web of Science ®Google Scholar
• Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf. 1994;11(5):318–377. doi: 10.2165/00002018-199411050-00004.
   PubMed Web of Science ®Google Scholar
• Schiffman SS, Zervakis J. Taste and smell perception in the elderly: effect of medications and disease. Adv Food Nutr Res. 2002;44:247–346. doi: 10.1016/s1043-4526(02)44006-5.
   PubMedGoogle Scholar
• Doty RL, Bromley SM. Effects of drugs on olfaction and taste. Otolaryngol Clin North Am. 2004;37(6):1229–1254. doi: 10.1016/j.otc.2004.05.002.
   PubMed Web of Science ®Google Scholar
• Uhlén M, Björling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics. 2005;4(12):1920–1932. doi: 10.1074/mcp.M500279-MCP200.
   PubMed Web of Science ®Google Scholar
• McLaughlin L, Mahon SM. Understanding taste dysfunction in patients with cancer. Clin J Oncol Nurs. 2012;16(2):171–178. doi: 10.1188/12.CJON.171-178.
   PubMed Web of Science ®Google Scholar
• Likhterov I, Ru M, Ganz C, et al. Objective and subjective hyposalivation after treatment for head and neck cancer: long-term outcomes. Laryngoscope. 2018;128(12):2732–2739. doi: 10.1002/lary.27224.
   PubMed Web of Science ®Google Scholar
• Likhterov I, Ru M, Ganz C, et al. Validazione italianadella chemotherapy induced taste alteration scale (CiTAS) [Italian validation of the chemotherapy induced taste alteration scale]. Assist Inferm Ric. 2016;35(1):22–28. Italian.
   PubMedGoogle Scholar
• Sozeri E, Kutluturkan S. The validity and reliability of Turkish version of the chemotherapy-induced taste alteration scale (CiTAS). Clin Nurs Res. 2018;27(2):235–249. doi: 10.1177/1054773816662436.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Lu Q, et al. Validation of the Chinese version of chemotherapy-induced taste alteration scale among patients with head and neck cancer undergoing radiotherapy. Eur J Oncol Nurs. 2020;48:101818. doi: 10.1016/j.ejon.2020.101818.
   PubMed Web of Science ®Google Scholar
• Drareni K, Bensafi M, Giboreau A, et al. Chemotherapy-induced taste and smell changes influence food perception in cancer patients. Support Care Cancer. 2021;29(4):2125–2132. doi: 10.1007/s00520-020-05717-1.
   PubMed Web of Science ®Google Scholar
• Santini D, Banna GL, Buti S, et al. Navigating the rapidly evolving advanced urothelial carcinoma treatment landscape: insights from Italian experts. Curr Oncol Rep. 2023;25(11):1345–1362. doi: 10.1007/s11912-023-01461-x.
   PubMed Web of Science ®Google Scholar
• Nizam A, Zhang L, Jindal T, et al. Biomarkers of treatment (Tx)-related toxicity in advanced urothelial carcinoma (aUC) pts treated with enfortumab vedotin (EV): analysis of UNITE study. Ann of Oncol. 2023;34(supple 2):S1219. doi: 10.1016/j.annonc.2023.09.1043.
   Google Scholar
• Reimann E, Kõks S, Ho XD, et al. Whole exome sequencing of a single osteosarcoma case–integrative analysis with whole transcriptome RNA-seq data. Hum Genomics. 2014;8(1):20. doi: 10.1186/s40246-014-0020-0.
   PubMed Web of Science ®Google Scholar
• Ho XD, Nguyen HG, Trinh LH, et al. Analysis of the expression of repetitive DNA elements in osteosarcoma. Front Genet. 2017;8:193. doi: 10.3389/fgene.2017.00193.
   PubMed Web of Science ®Google Scholar
• Ho XD, Phung P, Q Le V, et al. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples. Exp Biol Med (Maywood). 2017;242(18):1802–1811. doi: 10.1177/1535370217736512.
   PubMed Web of Science ®Google Scholar